LivaNova PLC
NASDAQ: LIVN · HEALTHCARE · MEDICAL DEVICES
Updated 2026-06-05
LivaNova PLC (LIVN) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for LIVN.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
LIVN historical valuation range
Where current P/E sits in LIVN's own 5Y range.
LIVN intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
LIVN valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 40.51x
P/S Ratio — History
Current: 3.04x
Is LIVN overvalued in 2026?
LivaNova PLC (LIVN) currently trades at $70.09 per share with a market capitalization of $4,361,174,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 52/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 40.5x, below its 5-year median of 40.6x. The PEG ratio of 0.91 suggests earnings growth is outpacing the multiple, a classic sign of undervaluation.
Looking at its own history, LIVN is currently trading more expensive than 50% of the last 5Y on P/E. This places it in the 50th percentile of its historical range, a reasonable but unremarkable position.
Our discounted cash flow model estimates LIVN's intrinsic value at $70.73 per share, against the current market price of $70.09. This implies a margin of safety of +6.08%. The stock is priced close to its estimated fair value, offering limited upside without further operational improvement.
The Piotroski F-Score of 4/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: LIVN trades at a fair valuation on our framework, with a Smart Value Score of 52/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is LIVN overvalued?
LIVN scores 52/100 on our Smart Value Score (Grade C), a mixed overall profile. The DCF also shows a positive margin of safety, so price and fundamentals line up reasonably well.
What is LIVN's fair value?
Our DCF model estimates LIVN's intrinsic value at $70.73 per share, versus the current price of $70.09, a margin of safety of +6.08%. Fair value is the present value of the cash flows we project the business to produce, so a price below it means the market is pricing the stock below that conservative estimate.
What P/E ratio does LIVN trade at?
LIVN trades at a P/E of 40.5x on trailing twelve-month earnings, against a 5-year median of 40.6x. P/E is what you pay per dollar of profit, and sitting below its own median means the stock is cheaper than usual relative to its earnings.
Is LIVN a buy based on valuation?
Our Smart Value rating for LIVN is Hold, from a Smart Value Score of 52/100 that blends growth, quality, and valuation. The profile is balanced and best suited to investors who already have a thesis. This is research to inform your decision, not personalized financial advice.
How does LIVN's valuation compare to its history?
On P/E, LIVN sits in the 50th percentile of its own 5Y range, above its long-run median relative to where it has traded. A high percentile means today's multiple is near the top of its historical band.
What is LIVN's Smart Value Score?
LIVN's Smart Value Score is 52/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.